
First Patient Enrolled in Phase 2 Clinical Study Evaluating ARINA-1 for the Treatment of NCFBE
Renovion and COPD Foundation Joint Release – Renovion, Inc. has announced that the first patient has been enrolled in a Phase 2 clinical...
First Patient Enrolled in Phase 2 Clinical Study Evaluating ARINA-1 for the Treatment of NCFBE
Renovion Receives Notice of Study May Proceed Status for Lung Transplant Program
Marty Zamora, MD, joins Renovion, Inc. as Chief Medical Officer
Renovion Provides Regulatory Update and Initiation of Clinical Program in Non-CF Bronchiectasis
A breathe-easier breakthrough
Exploristics signs collaboration agreement with Renovion, using the cloud-based simulation platform
Renovion and the COPD Foundation Launch COPD and Bronchiectasis Development Partnership
Renovion Announces Addition of Rich Mattingly to Board of Directors
Publication of Research Demonstrating the Impact of ARINA-1 on Mucus Transport in Cystic Fibrosis